Innate immunity to RNA virus is regulated by temporal and reversible sumoylation of RIG-I and MDA5
Related Experiment Video
Updated: Mar 7, 2026

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
Ming-Ming Hu1, Chen-Yang Liao1, Qing Yang1
1Medical Research Institute, Collaborative Innovation Center for Viral Immunology, School of Medicine, Wuhan University, Wuhan 430071, China.
Abstract:
Sensing of viral RNA by the cytosolic receptors RIG-I and melanoma differentiation-associated gene 5 (MDA5) leads to innate antiviral response. How RIG-I and MDA5 are dynamically regulated in innate antiviral response is not well understood. Here, we show that TRIM38 positively regulates MDA5- and RIG-I-mediated induction of downstream genes and acts as a SUMO E3 ligase for their dynamic sumoylation at K43/K865 and K96/K888, respectively, before and after viral infection. The sumoylation of MDA5 and RIG-I suppresses their K48-linked polyubiquitination and degradation in uninfected or early-infected cells. Sumoylation of the caspase recruitment domains of MDA5 and RIG-I is also required for their dephosphorylation by PP1 and activation upon viral infection. At the late phase of viral infection, both MDA5 and RIG-I are desumoylated by SENP2, resulting in their K48-linked polyubiquitination and degradation. These findings suggest that dynamic sumoylation and desumoylation of MDA5 and RIG-I modulate efficient innate immunity to RNA virus and its timely termination.
Insights
TRIM38 regulates innate antiviral immunity by controlling the dynamic sumoylation of RIG-I and MDA5. This post-translational modification balances receptor stability and activation, ensuring an effective and timely antiviral response.
Area of Science:
- Immunology
- Molecular Biology
- Virology
Background:
- Cytosolic RNA sensors, RIG-I and MDA5, are crucial for innate antiviral immunity.
- The dynamic regulation of RIG-I and MDA5 during antiviral responses remains unclear.
Purpose of the Study:
- To investigate the role of TRIM38 in regulating MDA5 and RIG-I.
- To elucidate the mechanisms controlling the dynamic modification and activity of MDA5 and RIG-I.
Main Methods:
- Investigated TRIM38's function as a SUMO E3 ligase for MDA5 and RIG-I.
- Analyzed sumoylation sites (K43/K865 for MDA5, K96/K888 for RIG-I).
- Examined the impact of sumoylation on ubiquitination, degradation, dephosphorylation, and activation of MDA5 and RIG-I.
Main Results:
- TRIM38 positively regulates MDA5- and RIG-I-mediated gene induction.
- Sumoylation of MDA5 and RIG-I by TRIM38 suppresses their ubiquitination and degradation.
- Sumoylation is essential for PP1-mediated dephosphorylation and activation of MDA5 and RIG-I.
- SENP2-mediated desumoylation at late infection stages leads to MDA5 and RIG-I degradation.
Conclusions:
- Dynamic sumoylation and desumoylation of MDA5 and RIG-I are critical for effective RNA virus innate immunity.
- This regulatory mechanism ensures both efficient viral clearance and timely termination of the immune response.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Viruses with RNA Genomes
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Leaky Scanning
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...

